Vinpocetine Exerts Neuroprotective Effects via Downregulating α-Syn in Rotenone-induced Cellular Models of Parkinson's Disease

被引:0
作者
Ji, Meng [1 ]
Xu, Ji-Hua [1 ]
Mi, He-Yin [1 ]
Jiang, Peng [1 ]
Li, Yue [1 ]
机构
[1] Capital Med Univ, Beijing Chao Yang Hosp, Dept Neurol, Beijing 100020, Peoples R China
关键词
Parkinson's disease; Vinpocetine; alpha-synuclein; Cytotoxicity; Dopaminergic; Polyvinylidene fluoride; ISCHEMIC-STROKE;
D O I
10.2174/0115701808274204231012111936
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Objective: Vinpocetine (Vinp), a derivative of alkaloid vincristine with anti-inflammatory and antioxidant effects, has been shown to have neuroprotective effects in Parkinson's disease (PD). Its role and mechanisms, however, are not fully understood. Therefore, the aim of this study was to investigate the effects and possible mechanisms of Vinp on PD cells.Methods: SH-SY5Y cells were treated with Vinp and then with rotenone to induce a cellular model of PD. The proliferation level and apoptosis rate of SH-SY5Y cells after different treatments were detected by MTT and flow cytometry assays, respectively. Western blot was used to determine the relative protein expression of alpha-Synuclein (alpha-Syn) in differently treated cells. Additionally, commercial kits and ELISA were used to determine oxidative stress-related indicators (superoxide dismutase (SOD), malondialdehyde (MDA), and reactive oxygen species (ROS)) and inflammatory factors (tumor necrosis factor alpha [TNF-alpha], interleukin-5 (IL-5), and interleukin-1 beta (IL-1 beta)) in SH-SY5Y cells after different treatments, respectively.Results: Vinp at different concentrations (5, 10, and 50 mu M) had no significant effect on the proliferation and apoptosis of SH-SY5Y cells. For rotenone-induced SH-SY5Y cells, Vinp pretreatment could significantly reduce alpha-Syn expression, increased cell viability and decreased apoptosis, oxidative stress (downregulation of ROS and MDA levels and upregulation of SOD activity) and inflammation (increased levels of TNF-alpha, IL-5, and IL-1 beta). In contrast, overexpression of alpha-Syn in SH-SY5Y cells with Vinp pretreatment and rotenone induction partially reversed the aforementioned protective effects of Vinp, causing a decrease in proliferation, an increase in apoptosis rate, inflammation, and oxidative stress.Conclusion: Vinp exerted neuroprotective effects by downregulating alpha-Syn to promote proliferation, inhibit apoptosis, and inhibit oxidative stress and inflammation in rotenone-induced SH-SY5Y cells.
引用
收藏
页码:3060 / 3067
页数:8
相关论文
共 39 条
  • [1] VINPOCETINE-BASED THERAPY IS AN ATTRACTIVE STRATEGY AGAINST OXIDATIVE STRESS-INDUCED HEPATOTOXICITY IN VITRO BY TARGETING NRF2/HO-1 PATHWAY
    Abdelmageed, Noha
    Twafik, Wael Ahmed-Anwar
    Seddek, Abdel-latif
    Morad, Samy Abdel-Raouf Fahim
    [J]. EXCLI JOURNAL, 2021, 20 : 550 - 561
  • [2] Role of vinpocetine in ischemic stroke and poststroke outcomes: A critical review
    Al-Kuraishy, Hayder M.
    Al-Gareeb, Ali I.
    Naji, Marwa Thaier
    Al-Mamorry, Farah
    [J]. BRAIN CIRCULATION, 2020, 6 (01) : 1 - 10
  • [3] Alexander Garrett E, 2004, Dialogues Clin Neurosci, V6, P259
  • [4] α-Synuclein misfolding and Parkinson's disease
    Breydo, Leonid
    Wu, Jessica W.
    Uversky, Vladimir N.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2012, 1822 (02): : 261 - 285
  • [5] Parkinson's Disease: Clinical Review and Update
    Cabreira, Veronica
    Massano, Joao
    [J]. ACTA MEDICA PORTUGUESA, 2019, 32 (10) : 661 - 670
  • [6] Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management
    Chang, Anna
    Fox, Susan H.
    [J]. DRUGS, 2016, 76 (11) : 1093 - 1118
  • [7] The Parkinson Pandemic-A Call to Action
    Dorsey, E. Ray
    Bloem, Bastiaan R.
    [J]. JAMA NEUROLOGY, 2018, 75 (01) : 9 - 10
  • [8] MDS evidence-based review of treatments for essential tremor
    Ferreira, Joaquim J.
    Mestre, Tiago A.
    Lyons, Kelly E.
    Benito-Leon, Julian
    Tan, Eng-King
    Abbruzzese, Giovanni
    Hallett, Mark
    Haubenberger, Dietrich
    Elble, Rodger
    Deuschl, Guenther
    [J]. MOVEMENT DISORDERS, 2019, 34 (07) : 950 - 958
  • [9] The rotenone model of Parkinson's disease: genes, environment and mitochondria
    Greenamyre, JT
    Betarbet, R
    Sherer, TB
    [J]. PARKINSONISM & RELATED DISORDERS, 2003, 9 : S59 - S64
  • [10] The role of Toll-like receptors and neuroinflammation in Parkinson's disease
    Heidari, Arash
    Yazdanpanah, Niloufar
    Rezaei, Nima
    [J]. JOURNAL OF NEUROINFLAMMATION, 2022, 19 (01)